Guardant Health price target raised to $120 from $100 at BofA

7 hours ago 6

TipRanks

Tue, December 16, 2025 astatine 9:41 AM CST 1 min read

BofA raised the firm’s price target connected Guardant Health (GH) to $120 from $100 and keeps a Buy standing connected the shares. The steadfast is updating it terms targets for Life Sciences & Diagnostic Tools stocks nether its coverage, the expert tells investors. Headwinds are expected to fade, and markets are expected to normalize successful 2026, steadfast adds. The steadfast believes the biggest upside for the assemblage volition beryllium a instrumentality to spending by Biopharma, starring BofA to favour companies with higher vulnerability to probe and development.

Unlock hedge-fund level information and almighty investing tools designed to assistance you marque smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation truthful your portfolio is ever positioned for maximum potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected GH:

Disclaimer & DisclosureReport an Issue

Guardant Health terms people raised to $155 from $115 astatine Leerink
Guardant Health: Strong Growth Potential and Market Positioning Justify Buy Rating
Guardant Health terms people raised to $120 from $90 astatine JPMorgan
Guardant Health terms people raised to $120 from $93 astatine Wells Fargo
Guardant Health terms people raised to $120 from $85 astatine Barclays

Read Entire Article